301060 logo

Shanghai Labway Clinical Laboratory Co., Ltd Stock Price

SZSE:301060 Community·CN¥3.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

301060 Share Price Performance

CN¥0
-10.02 (-100.00%)
CN¥0
-10.02 (-100.00%)
Price CN¥0

301060 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet second-rate dividend payer.

3 Risks
1 Reward

Shanghai Labway Clinical Laboratory Co., Ltd Key Details

CN¥1.5b

Revenue

CN¥1.2b

Cost of Revenue

CN¥321.9m

Gross Profit

CN¥391.5m

Other Expenses

-CN¥69.5m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 29, 2026
-0.17
21.12%
-4.56%
11.7%
View Full Analysis

About 301060

Founded
1993
Employees
1365
CEO
Weixiong Zeng
WebsiteView website
www.labway.cn

Shanghai Labway Clinical Laboratory Co., Ltd. engages in the sale of in-vitro diagnostic products in China. The company distributes in-vitro diagnostic instruments, reagents, and related accessories and consumables. It also provides third-party medical testing, pathological diagnosis services, precision medicine, CRO, and sample bank laboratory services; scientific research technology and testing; and professional technical support services. In addition, the company offers rental, business, and human resources services. Further, it operates Lanwei Academy that provides open courses and internal training. The company serves medical and scientific research institutes. Shanghai Labway Clinical Laboratory Co., Ltd. was founded in 1993 and is headquartered in Shanghai, China.

Recent 301060 News & Updates

Recent updates

No updates